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I. INTRODUCTION 
DIABETES 
Diabetes is a defect in the ability of the body to convert glucose (sugar) to 
energy. Glucose is the main source of energy in our body. When food is 
digested it is metabolized into fats, proteins, or carbohydrates. Glucose is 
then transferred to the blood and is used by the cells for energy production. 
For transferring of glucose, the hormone - insulin is needed which is mainly 
secreted by pancreatic beta cells. DM is a type of metabolic disorder that is 
characterized by increased glucose production in the blood with 
disturbances in metabolism of carbohydrate, protein and fat mainly due to 
defects in insulin secretion, its action or both.
 
If this hyperglycemic stage of diabetes persists for a long time, it is 
associated with long-term complications like improper functioning and 
failure of different organs causing deep damage to the eyes, kidneys, 
nerves, heart, and blood vessels.
 
CLASSIFICATION OF D.M: 
Two major classes of D.M. are proposed by the WHO committee 1980 and 
named them as insulin dependent diabetes mellitus (IDDM) and non- 
insulin dependent diabetes mellitus (NIDDM). These are again named as 
Type-1 and Type-2 diabetes respectively. In the 1985 study group these 
type-1 and type-2 are omitted and only IDDM and NIDDM are retained. 
The other types included in both 1980 and 1985 reports are impaired 
glucose tolerance as well as Gestational diabetes.
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Mainly there are two types of diabetes:
  
• Type 1 diabetes:  
In this type there is β cell dysfunction, usually causing complete insulin 
deficiency. Again is of two types 
A. Immune mediated 
B. Idiopathic 
Type 1 diabetes occurs most frequently in children and young adults. It 
majorly occurs genetically with no disease history but the correct cause is 
not yet known 
• Type 2 diabetes:  
This type ranges from predominant insulin resistance with relative insulin 
deficiency to a defect in secretion of insulin. This is a common type and 
accounts for 90-95% of all cases. This type primarily affects adults, rarely 
developing in children. Strong correlation exists between Type 2, physical 
inactivity and obesity.
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INSULIN RESISTANCE 
Insulin resistance (IR) is a situation in which cells fail to react to the 
regular measures of the hormone insulin. The body produces insulin; 
however the cells in the body develop into resistant to insulin and are 
incapable to use it as successfully, foremost to hyperglycemia. Beta cells in 
the pancreas consequently increase their creation of insulin, additional 
contributing to hyper Insulinemia. This repeatedly remains hidden and can 
donate to a diagnosis of type 2 diabetes.
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One of insulin's functions is to control release of glucose into cells to give 
them through energy.  Insulin resistant cells cannot capture in glucose, fatty 
acids and amino acids. Therefore glucose, fatty acids and amino acids 
escape out of the cells. A decrease in insulin or glucagon proportion inhibits 
glycolysis which in turn decreases energy making. The resultant raise in 
blood glucose might raise levels exterior the normal range as well as reason 
adverse health effects depending on dietary situation. Confident cell types 
such as fat as well as muscle cells need insulin to take in glucose. While 
these cells not succeed to respond sufficiently to circulating insulin blood 
glucose levels increase. The liver helps control glucose levels through 
reducing its emission of glucose in the attendance of insulin. This usual 
decrease in the liver glucose fabrication may not happen in people through 
insulin resistance. 
Insulin resistance within muscle and fat cells reduces glucose uptake while 
insulin resistance in liver cells consequences in condensed glycogen 
synthesis along through storage and also a breakdown to restrain glucose 
production as well as discharge into the blood. Insulin resistance usually 
refers to condensed glucose lowering special effects of insulin. Though 
extra functions of insulin can also be exaggerated. For example insulin 
resistance in fat cells decreases the usual things of insulin on lipids in 
addition to results in condensed uptake of circulating lipids and 
increased hydrolysis of stored triglycerides. Improved mobilization of 
stored lipids within these cells elevates free fatty acids in the blood plasma. 
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Elevated blood fatty acid concentrations condensed muscle glucose uptake 
and greater than before liver glucose production all contribute to important 
blood glucose levels. High plasma levels of insulin and glucose due to 
insulin resistance are a major constituent of the metabolic syndrome. If 
insulin resistance exists additional insulin desires to be secreted by the 
pancreas. If this compensatory enlarge does not happen, blood glucose 
concentration raise along with type 2 diabetes occurs.  
INSULIN RESISTANCE SYMPTOMS
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The signs and symptoms of insulin resistance syndrome include: 
 Impaired fasting blood sugar, High blood pressure.  
 Atypical cholesterol levels. 
 Heart disease.  
 Obesity. 
RISK FACTORS  
      Several risk factors include   
 Genetic factors (inherited component) 
 family history with type 2 diabetes 
 insulin receptor mutations 
 Particular physiological conditions and environmental factors 
 Obesity 
 Lack of physical exercise, sedentary lifestyle. 
 Hypertension. 
 High triglyceride level. 
 Low level of High density lipoproteins  
 Gestational diabetes during past pregnancies.  
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CAUSES OF INSULIN RESISTANCE  
Even though the correct causes of insulin resistance are not completely 
understand, scientists believe the main contributors to insulin resistance 
are overload weight along with physical inactivity.  
Excess Weight  
Obesity, particularly excess fat approximately the waist, is a major cause of 
insulin resistance. conversely, studies include revealed that belly fat 
produces hormones along with other substances that can cause serious 
health problems such as insulin resistance, high blood pressure, imbalanced 
cholesterol, and cardiovascular disease (CVD).  
Belly fat plays a division in developing chronic, or long lasting, 
inflammation in the body. Chronic inflammation is able to injure the body 
more than time, not including any signs or symptoms. This tenderness can 
make a payment to the growth of insulin resistance, type 2 diabetes, and 
CVD. Study demonstrate that lose the weight be able to decrease insulin 
resistance as well as prevent or stoppage type 2 Diabetes.  
Physical Inactivity  
A lot of studies have shown to facilitate physical inactivity is connected 
through insulin resistance, frequently leading to type 2 diabetes. During the 
body, additional glucose is used by muscle than additional tissues. Usually, 
active muscles burn their stored glucose intended for energy as well as refill 
their reserves through glucose taken beginning the bloodstream, 
maintenance blood glucose levels in balance.  
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Studies demonstrate that after exercising, muscle develops into more 
responsive to insulin, reversing insulin resistance as well as lowering 
blood glucose levels. Work out also helps muscles absorb additional 
glucose with not to be the need for insulin. The additional muscle a 
remains has, the additional glucose it can glow to manage blood glucose 
levels.  
Other Causes  
Other causes of insulin resistance may include ethnicity; certain diseases; 
hormones; steroid use; some medications; older age; sleep problems, 
especially sleep apnea; and cigarette smoking. 
HYPERGLYCEMIA 
Hyperglycemia or high blood sugar is a state in which a too much 
quantity of glucose circulates in the blood plasma. This is normally a 
glucose level elevated than 11.1 mmol/l (200mg/dl).
 
Polyuria - increased volume of urination
 
Polyphagia- frequent hunger, especially pronounced hunger 
Polydispia - frequent thirst, especially excessive thirst 
Fatigue (sleepiness)  
blurred vision  
Dry mouth 
Weight loss 
Erectile disfunction 
Cardiac arrhythmia. 
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Stupor 
Seizures 
Poor wound healing (cuts, scrapes, etc.) 
Dry or itchy skin 
Recurrent infection, external ear infections (swimmer's ear) 
Tingling in feet or heels 
Coma 
 
CAUSES OF HYPERGLYCEMIA 
Diabetes mellitus 
Chronic hyperglycemia to facilitate persists yet in fasting states is the 
majority generally caused by diabetes mellitus. In truth, chronic 
hyperglycemia is the major distinguishing of the disease. Irregular 
hyperglycemia might be near in prediabetic states. Acute episodes of 
hyperglycemia not including diabetes mellitus. 
Drugs 
Some medications increase the risk of hyperglycemia, including and Beta 
blockers, epinephrine Thiazide diuretics, niacin, pentamidine, protease 
inhibitors, Corticosteroids, octriotide Some  Antipsychotic agents. The 
sensitive administrations of stimulants such as amphetamine typically 
produce hyperglycemia. Various of the newer psychotropic medications, 
such while Olanzapine along with Duloxetine, can also cause considerable 
hyperglycemia. 
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Critical illness 
A high amount of patients distress an severe stress such while stroke 
or myocardial infarction might enlarge hyperglycemia, still within the 
nonexistence of a diagnosis of diabetes. Human as well as animal studies 
advise to facilitate this is not gentle, furthermore to facilitate stress induced 
hyperglycemia be connected through a elevated risk of mortality later than 
both stroke with myocardial infarction.  
The following situation is able to also cause hyperglycemia within the 
deficiency of diabetes.  
1. Dysfunction of the thyroid, adrenal, as well as pituitary glands  
2. A mixture of diseases of the pancreas  
3. Severe increases in blood glucose might be seen within sepsis as 
well as convinced infections 
4. Intracranial diseases are able to also cause hyperglycemia. 
Encephalitis, brain tumors, brain bleeds, along with meningitis is 
prime examples. 
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 HYPERLIPIDEMIA 
Hyperlipidemia is a situation overload of fatty substances called 
lipids, mostly cholesterol as well as triglycerides, during the blood. It is 
moreover called hyperlipoproteinemia since these fatty substances pass 
through in the blood attach to proteins  
In General Hyperlipidemia be able to be separated Into Two Subcategories 
    1. Hypercholesterolemia, in which here is a elevated level of cholesterol 
    2. Hypertriglyceridemia, in which near is a elevated stage of 
triglycerides, the a large amount general form of fat. 
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SIGNS AND SYMPTOMS OF HYPERLIPIDEMIA 
Hyperlipidemia typically has rejection noticeable symptoms as well as 
tends to be discovered through routine assessment or estimate meant for 
atherosclerotic cardiovascular disease. 
1. Chest Pain 
2. Liver Enlarged 
3. Abdominal Pain 
4. Heart attacks 
5. Enlarged Spleen 
6. High cholesterol or triglyceride levels 
7. Pimple like lesions across body 
8. Atheromatous plaques in the arteries 
9. Xanthelasma of eyelid 
10. Higher rate of obesity and glucose intolerance 
11. Xanthoma 
CAUSES OF HYPERLIPIDEMIA 
1. Diabetes (type 2) 
2. Pregnancy 
3. Environmental and genetic factors 
4. Nephrotic Syndrome 
5. Kidney disease 
6. An under active thyroid gland 
7. Hypothyroidism 
8. Alcohol 
9. Cushing’s Syndrome 
10. Anorexia Nervosa 
11. Obstructive Jaundice 
12. Estrogen therapy 
13. Lipoprotein lipase mutations 
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14. .  High dietary simple carbohydrates 
15. Lifestyle contributors include obesity, not exercising, and smoking. 
COMPLICATIONS 
 TYPES OF COMPLICATIONS: 
They are two types of complications they are.  
MICRO VASCULAR 
 Diabetic neuropathy 
 Diabetic nephropathy 
 Diabetic retinopathy 
MACRO VASCULAR 
 Atherosclerosis 
 Stroke 
 
Diabetic Nephropathy  
Diabetic nephropathy is a general and severe complication everywhere 
kidneys are damaged and fails to function. The cause is due to unrelenting 
high blood sugar level in the blood. In the premature phase of nephropathy 
drugs along with diet can manage the condition. The situation while protein 
start leaking in urine is called as microalbuminuria.  The general symptoms 
are kidney failure and weakness, decreased appetite, nausea and vomiting. 
Anemia might also be identified in diabetic nephropathy. It has been 
identified that about 30 to 40 % of Type I diabetics and 20 to 30% of Type 
2 diabetics develop reasonable to severe kidney failure. Diabetes 
myonecrosis might increase previous to or at the occasion of diagnosis of 
diabetes; normally it is a category of gangrene caused by Clostridium 
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bacteria. The toxins formed with the bacterium leads to tissue diabetic 
mastopathy frequently seen in premenopausal women distress as of Type 1 
diabetes intended for several years among insulin therapy. even though 
especially rare, it be able to be alive seen in men through diabetes because 
diabetic mastopathy, which is connected through micro vascular 
complications such while injure to the eyes, heart and kidneys or further 
disorders such like thyroid difficulty. 
Diabetic neuropathy 
Diabetic neuropathies are neuropathic disorders that are linked 
through diabetes mellitus. This situation is consideration to result since 
diabetic micro vascular injury involving minute blood vessels that supply 
nerves (vasa nervorum). Moderately ordinary conditions which might be 
linked with may be associated with diabetic neuropathy include diabetic 
amyotrophy, mononeuropathy, a painful polyneuropathy, mononeuropathy 
multiplex, autonomic neuropathy in addition thoraco abdominal 
neuropathy.  
 The major risk factor for diabetic neuropathy is hyperglycemia. 
period of diabetes, age, hypertension, height and hyperlipidemia are 
moreover risk factor for diabetic neuropathy. 
They are four factors thought to be involved in the development of diabetic 
neuropathy. 
 Micro vascular disease 
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 Advanced glycation end product,  
 Protein kinase C and 
 Polyol pathway 
Vascular along with neural diseases are directly associated to 
intertwined. Blood vessels depend going on regular nerve purpose, along 
with nerves depend resting on sufficient blood flow. The primary 
pathological adjust within the micro vascular is vasoconstriction. Because 
the illness progresses neuronal dysfunction correlates strongly through the 
growth of vascular abnormalities, such like capillary basement covering 
thickening as well as endothelial hyperplasia which donate toward 
diminished oxygen stress along with hypoxia. Neuronal ischemia is a fine 
recognized quality of diabetic neuropathy. 
Micro vascular dysfunction occurs near the beginning in diabetes parallels 
the series of neural dysfunction, along with might survive enough toward 
carry the strictness of structural, practical, plus medical changes identified 
in diabetic neuropathy. Important intracellular levels of glucose causes a 
non enzymatic covalent bonding through proteins, which change their 
arrangement with demolish their function. a number of of these 
glycosylated proteins include been implicated within the pathology of 
diabetic neuropathy as well as additional extended phrase compilations of 
diabetes.  
An investigational fact has so far to conform that the polyol pathway really 
is responsible for micro vascular injure in the retina, kidney or neurons of 
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the body. Nevertheless, physiologist are practically certain that it plays 
various role in neuropathy. 
Diabetic neuropathy affects every peripheral nerves pain fibres motor 
neurons autonomic nerves. But they automatically be able to affect every 
organs as well as systems because all are innervated. Here are more than a 
few distinct syndromes based resting on the organ system moreover 
members exaggerated except these are by no means exclusive. A patient be 
able to contain sensory motor plus autonomic neuropathy otherwise some 
new mixture. 
The mechanisms of diabetic neuropathy are badly implicit. On present 
management alleviates tenderness as well as be able to control various 
linked symptoms however the development is normally progressive.  Since 
a difficulty here us a improved threat of damage toward the feet for the 
reason that loss of sensation. Minute infection is able to progress to 
ulceration along with this might need exclusion. During adding motor nerve 
injure be able to psychotic break as well as inequality. 
Diabetic Retinopathy 
Retinopathy is characterized through improved vascular 
permeability, with vascular closure mediated through the development of 
original blood vessels neo vascularization, resting on the retina along with 
posterior surface of the vitreous. Diabetic retinopathy is a micro vascular 
disease, characterized through damage of the blood vessels along with 
retina of the eyes. This situation occurs during mutually in type 1 and type 2 
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diabetics. It be able to be classify as no proliferative diabetic retinopathy 
along with proliferative diabetic retinopathy otherwise diabetic macular 
edema. During diabetic retinopathy, the micro vessel supplying blood 
toward the retina of eye is exaggerated along which can cause blindness. 
Retinopathy is connected toward high blood sugar level along with 
obstructs the stream of oxygen toward the cells of the retina. Intended for 
the vision of eye, retina receives signals of radiance along with sent them 
toward the brain forming a three dimensional stature which is recognized. 
Lastly it is sent backside to the eye through which one can identify the 
belongings approximately. This functioning machine of transient light 
throughout the retina is caught up through the elevated glucose levels. The 
early phase of this disease is recognized as none proliferate Diabetic 
retinopathy somewhere the same as Proliferative diabetic retinopathy is the 
higher appearance of diabetic retinopathy during which original as fine as 
frail blood vessels rupture as well as escape blood into vitreous of the eye 
causing suspended spot during the eye. Progressively, the distended as well 
as blemish nerve tissue of the retina is completely damaged along through 
leads to retinal detachment. The ground reason for blindness between 
diabetes is owing to the retinal disinterest. Macular edema is regularly a 
complication of diabetic retinopathy which causes vision loss within public 
among diabetes. It develops while blood vessels during the retina are 
leaking fluids. The macula does not utility correctly while it is inflamed 
along with vision defeat might be calm toward severe, however peripheral 
apparition remains.
15
 Cataracts were reported while a main cause of 
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blindness as well as diabetic retinopathy. Longer period of diabetes 
unrestrained diabetes as well as maculopathy be moreover considerably 
connected through the occurrence of cataracts between these type 2 
diabetics. 
Insulin action 
Insulin is the essential hormone for maintenance the organism 
on a metabolically r e a s o n a b l e  situation and it does so by suggest 
a multiplicity of response in cells. In the majority cells insulin 
induces an anabolic action on protein, fat with glycogen as well as it 
motivate the expression of genes plus synthesis of DNA. In muscle as 
well as adipose cells, insulin stimulates the uptake of glucose, the 
most important method for continuation of glucose homeostasis in 
also. Insulin also induces a numeral of other cellular responses such as 
simulation of ion and amino acid uptake in cells, rearrangement of the 
cytoskeleton and instruction of a number of ce l lu lar  enzymes . The 
mechanism and Structure of the insulin receptor as well as the protein 
phosphorylation and dephosphorylation of seryl, threonyl and tyrosyl 
residues are the central mechanisms by which insulin affects cell 
function. 
Insulin Receptor with Tyrosine Kinase Activity 
 
 
The insulin receptor is a member of the family of receptors with a 
tyrosine (Tyr) kinase activity. Tyr-kinase receptors are 
transmembrane proteins with an extracellular part which contains 
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the hormone binding site and an intracellular part which consists 
of a particular amino acid sequence of approximately 300 amino 
acids encoding the catalytic domain of Tyr-kinase. The various 
Tyr-kinase domains found   in receptors are homologous but not 
identical. The common property of all these receptors is the 
activation of the ’Ayr-kinase upon hormone binding. The mechanism 
of Tyr-kinase activation involves ligand-induced dimerisation of 
receptors which bring the cytoplasmic regions with the Tyr-kinase 
domains in close locality to each other. As a result one receptor 
phosphorylates the other on multiple tyrosine residues and vice versa. 
This process  leads to the so called receptor autophosphorylation. 
Activation of Tyr-kinase receptors leads to in most cells to a 
mitogenic response. In addition cells may undergo differentiation. 
Among the members of the receptor Tyr-kinase family, the insulin 
receptor and its close re1ative insulin-like growth factor 1 (IGF-1) 
receptor are unique because only these receptors induce pronounced 
metabolic responses. In non disease states the insulin receptor is 
primarily involved in metabolic functions where as the IGF-1 
receptor mediates growth and differentiation. 
Insulin receptor and signaling 
The action of insulin is initiate during its necessary with the target cell 
surface receptor that activates tyrosine kinase, a element of the receptor 
molecule. The insulin receptor (IR) is a heterotetramer consisting of two α 
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subunits and two β subunits that are linked by disulphide bonds into a α1α2 
and β1β2 heterotetrameric complex. Insulin binds to the extracellular α -
subunit and transduces signals across the plasma membrane which activates 
the intracellular tyrosine kinase C terminal domain of the β subunit. Binding 
of insulin to IR effects a series of intermolecular transphosphorylation 
reactions, where one β subunit phosphorylates its adjacent Partner on a 
specific C tyrosine residue. Although IRs are present on the surface of 
virtually all cells, their expression in classical insulin target tissues, i.e. 
muscle, liver and fat, is extremely high. However, there is very little 
information on the regulatory mechanism that controls the IR at the level of 
gene expression. Autophosphorylation of the IR tyrosine residue stimulates 
the catalytic activity of receptor tyrosine kinase which recruits IRS proteins 
(IRS-1 and IRS-2). 
 
 
 
Fig no 1 INSULIN SIGNALING PATHWAY 
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GLUCOCORTICOID-INDUCED DIABETES MELLITUS 
Glucocorticoids have been shown to be potent anti-inflammatory and 
immunosuppressive drugs; they started to be used for therapeutic purposes 
in the mid-20th century, and are currently widely used in the treatment of 
many diseases.  
Although they are widely prescribed for their anti-inflammatory and 
immunosuppressive properties, glucocorticoids have a range of common 
metabolic side effects including hypertension, osteoporosis, and diabetes. 
Glucocorticoids exacerbate hyperglycemia in patients with diabetes 
mellitus, unmask undiagnosed diabetes mellitus or may precipitate the 
appearance of GIDM, which is an independent risk factor for other 
complications associated with the use of these drugs. It is expected that the 
blood glucose levels of non-diabetic patients should normalize after 
discontinuing glucocorticoid use, this does not always happen, and such 
patients require close monitoring due to the risk of developing diabetes 
mellitus in the future. 
PATHOPHYSIOLOGY 
The effects of glucocorticoids on glucose homeostasis are complex 
and not completely understood. Their negative effects are believed to be 
caused by a variety of factors, including increased insulin resistance, 
increased glucose intolerance, reduced β-cell mass from β-cell dysfunction, 
and increased hepatic insulin resistance leading to impaired suppression of 
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hepatic glucose production. The metabolic effects of glucocorticoids on 
glucose metabolism are seen at numerous stages in the insulin-signaling 
cascade. Prednisolone administration for 7 days in healthy volunteers led to 
a 50% reduction in insulin sensitivity, as assessed using the insulin clamp 
methodology. The effect of glucocorticoids on glucose metabolism likely 
results from the impairment of multiple pathways, including β-cell dys-
function (sensitivity to glucose and ability to release insulin) and insulin 
resistance in other tissues.  
 
 
 
Glucocorticoids reduce peripheral glucose uptake at the level of the 
muscle and adipose tissue. Skeletal muscle is primarily responsible for the 
insulin-mediated capture of postprandial glucose and corticosteroids can 
induce insulin resistance by interfering directly with various components of 
the insulin signaling cascade. Chronic glucocorticoid overexposure alters 
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body composition, including the expansion of adipose tissue depots in the 
trunk, and impairs metabolism and insulin action, resulting in hyper-
glycemia and dyslipidemia. The ability of glucocorticoids to induce adipose 
tissue lipolysis depends on their concentration, duration of exposure, and 
the specific adipose tissue depot.  
The liver plays a major role in the control of glucose metabolism, 
maintaining fasting euglycemia. Corticosteroids increase endogenous 
glucose production directly by activating numerous genes involved in the 
hepatic metabolism of carbohydrates, leading to increased gluconeogenesis. 
Glucocorticoids also inhibit the production and secretion of insulin from 
pancreatic β-cells. The abilities of glucocorticoids to induce hyperglycemia 
depend on their dose and the duration of exposure. In addition to insulin 
resistance, inflammatory disease states themselves may induce β-cell 
dysfunction through indirect mechanisms. 
GC’s provide a substrate for oxidative stress metabolism increasing 
lipolysis, proteolysis, and hepatic glucose production. The mechanism 
responsible for glucose intolerance after GC administration is similar to that 
of type 2 DM since steroids increase insulin resistance, which can be up to 
60%-80% depending on the dose and type used. Among the notable factors 
that modify the biological effects of steroids, there is the enzymatic activity 
of 11β-hydroxysteroid dehydrogenase, which is classified into two types: 
type 1, expressed in liver and adipose tissue and amplifies the local action 
of steroids to convert cortisone to cortisol, and type 2, which predominates 
in renal tissue and reduces the effect of converting cortisol to cortisone.  
21 
 
Skeletal muscle is responsible for 80% of postprandial glucose 
storage and represents the largest reserve of glycogen in the body. Its 
storage is totally dependent on the presence of insulin and the availability of 
the glucose transporter type 4 (GLUT4) glucose transporters in the cell 
membrane. Steroids induce insulin resistance by directly interfering with 
signaling cascades, mainly the GLUT4 transporter, within muscle cells, 
with the subsequent 30%-50% reduction in insulin-stimulate glucose uptake 
and a 70% reduction in insulin-stimulated 
MECHANISMS OF GLUCOCORTICOID-INDUCED DIABETES 
MELLITUS 
 Reduced peripheral insulin sensitivity and/or promotion of weight 
gain 
 Increase in glucose production through promotion of hepatic 
gluconeogenesis 
 Destruction of pancreatic cells, leading to β-cell injury 
(inflammation) 
 β-Cell dysfunction 
 Impaired insulin release 
 Impaired insulin release 
 Inhibited glyceroneogenesis 
 Increase in fatty acids 
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II. AIM AND OBJECTIVE  
AIM  
The aim of the present study was to evaluate the anti diabetic activity 
of ethanolic extract of aerial parts of Anisomeles malabarica Linn. 
OBJECTIVE: 
The objectives of the present research are as follows: 
 To prepare and standardize the ethanolic extracts of roots of 
Anisomeles malabarica Linn.  
 To establish the safety of the extract by carrying out acute and sub 
acute toxicity studies and investigating the behavioral changes in 
Wistar albino rats. 
 To investigate the antidiabetic effect ethanolic extracts of roots of 
Anisomeles malabarica Linn. against dexamethasone-induced insulin 
resistance in wistar albino rats. 
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III. REVIEW OF LITERATURE 
Review on Methodology 
Ramu Ravirala et al.,(2016) study was conducted to report the effect of 
Echinochloa frumentacea link on dexamethasone-induced insulin resistance 
in rats. Rats be treated with a dose of dexamethasone (10 mg/kg) for 10 
days with effect of HAEF at the doses of 200, 400 and 600mg/kg, p.o. on 
serum triglyceride level, plasma blood glucose level, body weight and 
antioxidant activity of DPPH, hydroxyl, nitric oxide, along with reducing 
power methods were observed. HAEF contain considerable antioxidant 
activity in DPPH, hydroxyl, nitric oxide, and reducing power methods. 
During the model HAEF at 400mg/kg and 600mg/kg p.o. showed 
considerable effect. Dexamethasone caused an raise in triglyceride levels, 
serum glucose, and decrease in body weight, thus it can be accomplished 
that Echinochloa frumentacea might prove to be effective in in vitro 
antioxidant property along with the treatment of Type-II Diabetes mellitus 
due to its capability to decrease insulin resistance.
 
 
Adejuwon adewale adeneye et al.,(2015) The  study conducts  the  result 
of the  10 mg/kg bromocriptine  in combination among 20 mg/kg  
metformin, 1 mg/kg glibenclamide, and both glibenclamide and 
metformin of oral treatments in combination, in lipids, blood glucose, 
body weight and cardiovascular risk report in male Wistar rats on 
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dexamethasone-induced  hyperglycemic  for  30 days. The resulted the 
effects of the drug combinations on OGTT treated rats were also 
evaluated. Repetitive every day dexamethasone injection used for 30 
days caused considerable increases in the  average body weight, 
triglycerides, blood glucose, LDL-C, total cholesterol, VLDL-C and  
cardiovascular  risk in the  treated  Wistar  rats.  However, the increase is  
considerably   attenuated in  rats orally pretreated through bromocriptine 
and its various combinat ions . Bromocriptine and its combinations 
considerably enhanced O G T T  in the treated rats. 
Shyamala Devi et al., (2014) conducted a study states that orally 1 g/kg 
Garcinia cambogia fruit extract along with Dexamethasone10 mg/kg 
subcutaneously were administered and treatment for 8 days. The treated 
dexamethasone resulted in distinct increase in the levels of cholesterol, free 
acids and triglycerides in both liver and plasma. The phospholipids level 
increased in the plasma but drastically decreased in liver tissue in rats when 
compared to normal group of rats. After dexamethasone administration the 
actions of acyl transferase, lecithin cholesterol, and liver lipoprotein lipase 
are decreased considerably.  The levels of HDL cholesterol and HDL 
triglycerides are remain unchanged, while the VLDL and LDL increased 
considerably in dexamethasone administered rats. When co treated rats with 
Garcinia cambogia extract and dexamethasone the lipid levels were 
maintained at normally. The concluded that Garcinia cambogia extract 
shows hypolipidemic property and dexamethasone administration study 
shows that undesirable changes in lipid profile. 
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Humberto Nicastro et al.,(2012) We designed to estimate the effect of 
resistance exercise and leucine supplementation with dexamethasone 
induced muscle atrophy with insulin resistance. Rats male Wister is 
randomly separated into four groups. Every group received dexamethasone 
5 mg/ kg for 7 days leucine supplemented groups received 0.135 g/ kg 
through gavages for 7 days. Plasma glucose was considerably increased in 
the dexamethasone and leucine group compare with the dexamethasone 
group and resistance exercise considerably decreased hyperglycemia. The 
dexamethasone and leucine group shows reduced glucose transporter 4 
translocation compared among the dexamethasone group and resistance 
exercise restored this response. Leucine supplementation worsened insulin 
compassion and did not assuage muscle wasting in rats treated with 
dexamethasone. On the other hand, resistance exercise modulated glucose 
homeostasis and fiber type conversion in the plantaris muscle. And 
Concluded that Resistance exercise but not leucine supplementation 
promoted fiber type transition and better glucose homeostasis in 
dexamethasone treated rats. 
Michele Barbera et al.,(2012) Reported a research, treated in the aging rats 
use glucocorticoid to increase insulin resistance in in-vivo and in-vitro 
outcome of the vanadyl sulfate an insulin mimetic agent. Daily 
Dexamethasone 0.13 mg/kg b.w. was administered for 13 days to old 
Sprague Dawley rats and from the 5th day vanadyl sulfate be given oral. 
Concentrations of Insulin, Plasma glucose, and free fatty acids were 
measured during these treatments at the end of the experiment the insulin 
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Secretory effect of the isolated perfused pancreas was assessed In 
Dexamethasone treatment Both young and aging rats, particularly the latter, 
hyperinsulinemia and improved in vitro insulin responsiveness to glucose 
be observed. Simultaneously the concentrations of an increase in plasma 
FFA. The Beta-cell adaptive answerd occurred in both age groups and could 
probably be increased circulating FFA In glucocorticoid-treated animals. 
70% of aging animals It is lacking to stop hyperglycemia. Oral vanadyl 
sulfate administration unsuccessful to correct Dex-induced alterations in 
metabolism of glucose and lipid, even though it prejudiced in vitro b-cell 
responsiveness to stimuli in aging rats. 
Dibyendu Shil et al.,(2012) The plan of this study was to assess the effect 
of potential hypoglycemic and hypolipidemic effect of Nepenthes khasiana 
Hook leaf extract on Hyperlipidemia and Insulin Resistance in 
Dexamethasone-induced Rats. The research was done at two dissimilar 
doses of 250 & 500 mg/kg p.o. on 11 of treatment. Serum glucose and lipid 
parameters are estimated by collecting the blood samples. 500 mg/kg p.o 
Standard glibenclamide next to a dosage was compared with the of leaf 
extract. Leaf extract and glibenclamide appreciably decreased (P<0.05) 
dexamethasone induced increase of serum glucose while compared to the 
control group. Dose of 500 mg/kg Leaf extract showed better activity than 
standard.  The research says that the leaf extract of Nepenthes khasiana 
Hook show significant glucose and lipid lowering activity. 
O. H. Azee et al.,(2011) the plan of this study was to assess the effect of 
Gundelia tournefortii on various hyperglycemic and hyperlipidemic 
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biochemical parameters in mice. Daily 1 mg/kg of body weight 
intramuscularly injected dexamethasone were induced hyperglycemic and 
hyperlipidemic in Male albino mice. The doses of G. tournefortii extract of 
at a 75, 150, 300 mg/kg.b.w. Orally correspondingly companied through 
injection of dexamethasone 1 mg/kg body weight intramuscularly. 
Treatment is for 22 days. Dexamethasone treatment shows that raise in 
levels of cholesterol, glucose, and triglyceride, and drastically decreases the 
body weight, with no result on level of overall protein. G. tournefortii drug 
extract treated at dose of 75 mg/kg.b.w. Shows considerable decrease levels 
of glucose, and body weight. Positive result were seen when mice treated 
with G. tournefortii at a dose of 300 mg/kg.b.w. so as to leads to 
considerable decrease in levels of triglyceride, glucose, and cholesterol. 
These outcomes indicate that helpfulness of G. tournefortii extract was 
hypoglycemia along with hypolipidemia during dexamethasone treated 
mice. 
Samir Bhattacharya et al.,(2010) Free fatty acids are well-known to play 
an important part in promoting loss of insulin sensitivity, in this manner 
causing insulin resistance and type 2 diabetes. Though, that underlying 
mechanism involved is undecided. During search intended for the reason of 
the mechanism, it has been originate that primary palmitate inhibits insulin 
receptor (IR) gene expression, to a decreased quantity of IR protein in 
insulin target cells. Causes decreased in insulin receptor gene expression 
when PDK1-independent phosphorylation of PKCε. throughout the 
pathways one of which fatty acid can bring insulin resistance in insulin 
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target cells is recommended by these studies. We give an overview of this 
essential area, emphasizing the existing status. 
Xiaoping Gao et al.,(2011) the special effects of Dioscorea opposita on 
dexamethasone-induced insulin resistance are investigate in vitro and in 
vivo. In dexamethasone-induced diabetic rats D. opposita extract decreased 
considerably the blood insulin along with glucose levels. D. opposita 
considerably improved insulin stimulated glucose uptake in 3T3-L1 
adipocytes in in-vitro. In addition D. opposita increases the mRNA term of 
GLUT4 glucose carrier in 3T3-L1 adipocytes. These records suggest that D. 
opposita have insulin sensitivity that is connected with the regulation of 
GLUT4 expression. 
Akhila J. Setty et al.,(2010) evaluated the effect of costus igneus leaves on 
dexamethasone induced hyperglycemia in male Wister rats. Commonly in 
India costus igneus is an Indian insulin plant belongs to the family 
costaceae. Lowers blood glucose levels, and diabetes and falling the blood 
sugar levels are the beneficial effects while consumption of the leaf. 
Animals were divided into 4 groups of six each (n=6) were treated for 20 
days with a dose of 10 mg/kg/day of dexamethasone subcutaneously. 
Animals received costus igneus at a dose of 100,200&500 mg/kg/day in 
distilled water from day 11 to day 20 orally or 500µg/kg of glipenclamide 
orally. After overnight fasting on 20
th
 day blood samples is collected by 
retro-orbital puncture for estimating the fasting blood glucose levels after a 
glucose load of 2.5mg/kg given orally 1 hour before for estimating the post 
glucose load blood glucose levels. The levels of fasting glucose and post 
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glucose load blood sugar levels are raised in dexamethasone treated group 
compared to normal group. Costus igneus at a dose of 250, & 500 mg/kg 
and 500µg/kg of glipenclamide decrease the dexamethasone induced 
hyperglycemia. The costus igneus leaves reduces the fasting and post 
prandial blood sugar levels decreases to normal in dexamethasone induced 
hyperglycemia31 
Neeharika V et al.,(2010) To investigate the effect of Madhuriktha a 
polyherbal formulation on dexamethasone and fructose induced insulin 
resistance. Administration of 10 mg/kg dose of Dexamethasone for 10 days 
through S.C rote and 10% w/v aqueous solution of fructose was feed for 20 
days in feeding bottles. After completion of treatment sacrifice the animal 
and collect the blood samples for biochemical parameters like insulin, 
cholesterol, triglycerides, LDL, HDL, and levels of glucose was estimated. 
The drug extract Madhuriktha at a dose of 200 and 400 mg/kg of drug 
shows effect able decreasing all the parameters like like insulin, cholesterol, 
triglycerides, LDL, HDL, and levels of glucose and better improved the 
body weights. 
Rashid Akthar et al.,(2010) The aim of the study is to investigate the 
effect of leaves of Tephrosia purpurea Linn extract to accepted the lipid 
lowering properties on experimentally proved dexamethasone induced rat. 
Tephrosia purpurea  Linn belongs to a family Fabaceae used for the 
treatment in diabetes. Low density lipoprotein cholesterol, Total 
cholesterol, very low density lipoprotein cholesterol, High density 
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lipoprotein cholesterol, Triglycerides and atherogenic are the lipid 
parameters studied. Orally the drug extract administered at a dose of 600 
and 1200 mg/kg in Dexamethasone induced rats. It shows the levels of low 
density lipoprotein cholesterol, Total cholesterol, very low density 
lipoprotein cholesterol and Triglycerides are significantly decreased. But 
when compared to control group of rats the High density lipoprotein 
cholesterol (HDLC) are considerably increased. Finally concluded that the 
leaves of Tephrosia purpurea Linn can significantly decreases the lipid 
levels
.
 
Sankara Sastry Pragda et al.,(2009) Hyper lipidemia is a major problem 
for developing diabetes mellitus and cardiovascular diseases. The 
herbaceous weed of P oleracea Linn comes under the family of 
Portulacaceae and having various pharmacological effects like antibacterial, 
anti inflammatory and antiplasmodial activity. The study is to investigate 
the effect of antihyperlipidemic activity on dexamethasone induced rats. For 
rats 10 mg/kg of dexamethasone was administered through subcutaneous 
route for 8 days shows hyperlipidimea and noticeable increase the level of 
serum cholesterol and triglyceride levels with increase in atherogenic 
effects. Here the drug Portulaca oleracea Linn are injected at the dose of 
200 and 400 mg/kg and finally the result shows that considerable decreases 
the levels of triglycerides and levels of levels of cholesterol against in rats 
of dexamethasone induced hyperlipidemia. 
31 
 
C. N. Okwuosa et al.,(2008) To investigate the effect on leaves extract of 
Pterocarpus santalinoides shows decreased level of triglyceride and 
glucose against induced hyperlipidemia as well as insulin resistance in rats. 
According to standard methods acute toxicity test was performed. And oral 
glucose tolerance test was done on the presence of extracts in normal rats. 
Then after a 12h fasting rats in four groups of respected doses of extracts of 
aqueous with methanolic extracts of P.santalinoides were administered 
orally and also glucocorticoid 10 mg/kg body wt administered through 
subcutaneous. In 5
th
 group rats received saline 5 ml/kg p.o and 
glucocorticoid 10 mg/kg body wt s.c and marked like positive control and 
sixth group named as normal control. Treatment period are 10 days. The 
acute toxicity test showed to that the extract had an oral LD50 is more than 
5000 mg/kg in rats. When extracts of glucose full normal rats shows 
significant decreasing of blood glucose levels started with at 90 min after 
glucose load when compared among the 60 min sample and also when 
differentiated with the negative control value at 90 min. 10 days 
administration of dexamethasone resulted hyperlipidemia and insulin 
resistance because of increasing blood glucose levels and triglycerides 
levels in positive control when compared with normal control. In 
dexamethasone induced hyperlipidemia and insulin resistance the P. 
santalinoides extracts shows the properties of triglyceride and glucose 
lowering effect.  
Md. Shalam, M.S. Harish et al.,(2006) To identify the decreasing 
effect of SH-01D on dexamethasone along with fructose induced 
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insulin resistance in rats. Here two methods are followed that is drug 
injected dexamethasone10 mg/kg through subcutaneous route, and 
orally fructose 10% w/v are given to the rats 10 to 20 days period 
correspondingly. Two respective doses of 30 and 60 mg/kg of SH-01D 
was followed. After completion of treatment the biochemical parameters 
like cholesterol, LDL, triglycerides, HDL, insulin and glucose are 
studied. After sacrificing the animals muscle and Liver were studied in 
fructose model. The result shows that 60mg/kg of SH-01D shows 
significant effect in both models. Serum biochemical parameters are 
increased in fructose model but in skeletal and liver glycogen levels are 
decreased. Serum glucose along with triglycerides levels are increased in 
Dexamethasone induced group. The dose of 60mg/kg SH-01D fructose 
fed rats is significantly stops the increasing serum biochemical 
parameters and also greatly reduces glycogen levels. Higher the glucose 
and triglycerides are prevented in SH-01D in dexamethasone model. 
Finally concluded that SH-01D are helpful in insulin resistance. 
C. Velmurugan et al.,(2006) Reported the effect on the leaves of 
Gossypium herbaceum (200mg/kg) on hypoglycemic and hypolipidemic 
effect of evaluated ethyl ether along with ethanolic fractions of 
dexamethasone induced diabetic rats. For animals diabetics’ diabetes are 
induced through dexamethasone 10 mg/kg of body weight s.c. orally treated 
with various fraction of Gossypium herbaceum. Standard drug 
Glibenclamide is used. As compared to diabetic control the fractions shows 
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significant (p<0.01) anti hyperglycemic and hypolipidemic activity. The 
fraction shows helpful effects on blood glucose. It also decreases the 
important biochemical parameters such like low density lipoprotein, 
triglycerides, total cholesterol and very low density lipoprotein, and 
maintains the body weight as increases the decreased level of high density 
lipoprotein. Finally both fractions are good for oral hypoglycemic agents 
and appear to be hopeful for the improvement of diabetes mellitus. 
Atsushi Ogawa al.,(2005) The roles of insulin resistance along with fl-cell 
dysfunction in Dexamethasone induced Insulin Resistance were studied in 
Wister rats. All rats are treated with 5 mg/kg of dexamethasone for 25 days 
shows improved f-cell mass with basal as well as arginine raised insulin 
secretion, shows insulin resistance, but only 17% become diabetic. The 
insulin reaction to 20 mM glucose was normal within the fused pancreas of 
every normoglycemic dexamethasone treated rats but not present in every 
diabetic rat. In Immunostainable more K. f-cell carrier, GLUT 2, be there in 
100% of f-cells of normoglycemic rats, except in only 27% of f- cells of 
diabetic rats. But there is no reduction of GLUT 2 mRNA. Diabetic and 
glucose raised insulin secretion was absent in every Zucker rats were 
treated with 0.2 to 0.4 mg/kg of dexamethasone for 25 days. More glucose 
transport into islets was 60% of low no diabetic controls. Compared among 
100% in controls diabetic rats were GLUT 2 positive up to 35% of cells. 
Increased two fold Total pancreatic GLUT 2 mRNA be signifying a 
posttranscriptional irregularity. We terminate that dexamethasone induces 
insulin resistance, whether it may or not it induces hyperglycemia. At 
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whatever time presence of hyperglycemia, good  GLUT 2 fi cells are 
decreased, more  K
+
 glucose transport into the  cells is attenuated as well as 
the insulin reaction to glucose is absent.  
Review on Plant 
1. R. Suthar Singh, M. Uvarani and S. Raghu Raman(2003) 
“Pharmacognostical and phytochemical studies on leaves of Anisomeles 
malabarica” The present study includes the morphological and anatomical 
characteristic of the leaf along with the determination of physio chemical 
constants, phytochemical screening and volatile oil content determination 
on the leaves of Anisomeles malabarica (LAMIACEAE) to provide some 
pharmocognostical standards and serves as a standard reference for the 
identification of Anisomeles malabarica.
 
 
2. R.Jeyachandran, A.Mahesh, L.Cindrella.(2007) “DEN-induced cancer 
and its alleviation by Anisomeles malabarica(L.) R.Br. ethanolic extract in 
male albino mice”. Anti-cancer activity was evaluated by measuring the 
activities of total protein, Glutamate pyruvate transaminase(GPT), 
glutamate oxaloacetate transaminase(ALP). The ethanolic extract at an oral 
dose of 100mk/kg exhibited a significant (p<0.05), protective effect by 
reduce liver and serum levels of total protein, GPT, GOT, ACP, ALP as 
compared to DEN induced mice. 
3. Ushir Y et al.,(2011) “HPTLC Fingerprint Profile For Quantitative 
Determination Of Various Phytoconstituents In Anisomeles Species”. 
Finger print of two ethano-botanically important Anisomeles species has 
been developed. A sensitive and reliable densitometric High Performance 
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Thin Layer Chromatography (HPTLC) method has been developed for the 
quantification of quercetin, β-sitosterol, stigmasterol, catechin and 
ovatodiolide present in Anisomeles indica and Anisomeles malabarica. 
Chromatographic analysis was performed using methanol, chloroform, 
acetone and ethanol extract of these plants were developed in the different 
solvents such as toluene, chloroform, ethyl acetate, methanol at various 
proportions. Detection and quantification of all phytoconstituents was done 
by densitometric scanning at different wavelengths. They reported finger 
prints would be helpful in the standardization of these species. 
4. R. Ranganathan and R. Vijayalakshmi(2012) “Effect of Anisomeles 
malabarica (L.) R.Br. Methanolic extract on DMBA - induced HBP 
Carcinogenesis”. The effect of Anisomeles malabarica(L.) R.Br. Whole 
plants extract has been studied on cellular redox status during hamster 
buccal pouch carcinogenesis. The buccal pouch AMME reversed the 
susceptibility to lipid peroxidation while simultaneously increasing GSH-
dependent antioxidant enzyme activities, whereas in the liver and 
erythrocytes, the extent of lipidperoxidation was reduced with elevation of 
antioxidants. Thus, modified oxidant status together with antioxidant 
adequacy in the target organ as well as in the liver and erythrocytes induced 
by AMME may significantly reduce cell proliferation and block tumor 
development in the HBP. 
5. Kavitha T, Nelson R, Thenmozhi  R, Priya,(2012)“Antimicrobial 
activity and phytochemical analysis of Anisomeles malabarica (L.) R.Br”. 
Invitro antibacterial activity of leaf extracts of A. malabarica against E.coli, 
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S.aureus, P.mirabilis, P.aeruginosa, k.pneumonia. The preliminary 
phytochemmical analysis of both Ethanolic and Diethyl ether extracts 
revealed the presence of alkaloids, flavonoids, tannins, saponins, and 
glycosides. It was found that the ethanolic extract exhibited a maximum 
antibacterial activity at 200μg/ml and produced 25mm zone of inhibition 
against S.aureus whereas Diethyl ether extract produced 30mm zone of 
inhibition in the same concentration. The results provide justification for the 
use of A. malabarica to treat various infectious diseases. 
6. M. Ismail Shareef, S. Leelavathi, Anis Ahmed Shariff. (2012). 
“Inhibition of Invitro TNF-α Production by Anisomeles malabarica R.Br. 
Reinforces Its Anti-Rheumatic and Immunomodulatory Properties”. Anti-
rheumatic and immunomodulatory role of aerial parts, leaves and roots in 
lipopolysaccharide (LPS) mediated signaling in macrophage and mouse 
connective tissue cell cultures were observed. Study employed tumor 
necrosis factor-α (TNF-α) bioassay, all the three extracts viz., aerial parts, 
leaves and roots inhibited TNF-α production in LPS (1 μg/mL) stimulated 
RAW-32 cells. 38.75 % inhibition of TNF-α was observed at 200 μg 
extracts of the aerial parts of the plant followed by 17.64 and 14.94 % by 
the roots and leaves respectively. These findings from the present in vitro 
studies suggest the anti-rheumatic and immunomodulatory properties of the 
methanolic extracts of A. malabarica. 
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IV. SCOPE AND PLAN OF WORK  
4.1 SCOPE OF WORK 
Diabetes is one of the commonest diseases, which is characterized by a 
selective and progressive degeneration of beta cells. The goal of therapeutic 
measures is to achieve conventional glucose levels (euglycemia), to lower 
the incidence of vascular and neuropathic complications, to reduce 
hypoglycemia, and to affect the patient’s lifestyle and activities as little as 
possible. The scope of the present work stays with the fact to prevent the 
beta cells from getting destroyed, the plant Anisomeles malabarica L.  is 
expected to protect the damage generated.  
4.2 PLAN OF THE WORK 
The plan of the work is given below. 
1. Collection and authentification of Anisomeles malabarica Linn. 
2. Preparation of ethanolic extracts by cold maceration  
3. Preliminary phytochemical screening of extracts.   
4. Toxicological investigation of the extracts. 
a. Acute toxicity study.  
b. Sub acute toxicity. 
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5. Evaluation of anti diabetic activity of the aerial parts of 
Anisomeles malabarica Linn. against Dexamethasone induced 
hyperglcemia. 
                     V. MATERIALS AND METHODS  
5.1 Plant Material 
Binomial Name: Anisomeles malabarica Linn. 
 
  
Fig 14: Anisomeles malabarica(L.)R.Br. 
Scientific classification  
 
Kingdom   :  Plantae  
Phylum   :  Charophyta  
Superorder   :  Asteranae  
Order    :  Lamiales  
Family   :  Lamiaceae  
Genus   :  Anisomeles  
Species  :  Malabarica 
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Vernacular Names 
 
Tamil      :        Peyimarutti 
                      Malayalam        :        Perumpumpa, Karintumpa 
                      English              :        Malabar Catmint 
                       
 
Distribution: Found throughout south India, in higher elevations.  
 
 
Plant Description 
A small perennial shrub grows upto 1.5 meters in height. Leaves simple, 
opposite, very thick, aromatic, oblong-lanceolate, acute, pale above, white 
below, crenate-serrate, soft woolly, flowers purple, in dense whorls of more 
or less interrupted spikes, fruits nutlets, bearing ellipsoid and compressed 
seed  
Properties and uses  
The plant is acrid, bitter, aromatic, intellect promoting, neurprotective, 
stomachic, antihelminthic, febrifuge and sudorific. It is useful in hailotis, 
epilepsy, hysteria, amentia, anorexia, diabetes, dyspepsia, colic flatulence, 
intestinal worms, fever arising from teething in children, intermittent fevers, 
vitiated conditions of vata and kapha, gout, swellings and diarrhoea. 
Authentification: 
Anisomeles malabarica Linn., was authenticated by Prof. Dr. P. Jayaraman 
Director, Plant Anatomy Research centre Tambaram. The specimen of the 
plant was maintained with voucher number PARC/201/1397.  
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5.2 Experimental Animals 
Albino Wistar rats of either sex approximately same age group were 
used after being acclimatized for a week at laboratory conditions. They 
were provided standard rodent pellet diet (Lipton India) and water ad 
libitum. The animals had free access to food and water and maintained 
under 12:12 hr light and dark cycle. All experiments were carried out 
during day time from 09.00 to 17.00 hr. The protocol was approved by 
Institutional Animal Ethical Committee and care of the animals was taken 
as per guidelines of committee for the purpose of control and supervision in 
experiments on animals (CPCSEA), representative of Animal Welfare, 
Government of India. Department of Biotechnology Sri Venkateswara 
College of Engineering, Paranur, Chennai - (SVCE/BIO/2017/004). Wistar 
Albino rat of 43 were sanctioned for the study (weight about 150-200 gm) 
Female rats of 3 numbers were used for the acute toxicity study; five 
male and female animals were used for the sub acute toxicity study. Male 
rats (n=6 x 6 Groups) were used for the antidiabetic study.  
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5.3 Instruments 
S.NO 
INSTRUMENTS MANUFACTURED  
COMPANY 
1 
UV-Visible 
Spectrophotometer 
UV-1800 Shimadzu, Model, Mfg 
by 
Shimadzu Carporation. 
2 
 
Centrifuge 
Research centrifuge, Mfg by 
Remi 
Instruments Ltd, Mumbai 
3 
Tissue Homogenizer Type: RO-127A, Mfg by 
Rajendra 
Elect, IND.Ltd, Remi Instruments 
Division, Vasai 
4 
Sonicator Pci made in Mumbai. 
5 
Milli pore water collector Mfg by TKA smart pure made in 
Made in Germany 
6 Soxhlet apparatus Agarwal 
7 Rotory evaporator Medika instrument Mfg co. 
8 UV chamber Singhla sciences, Ambala 
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5.4 Chemicals Used In This Study 
S.NO DRUGS AND CHEMICALS 
MANUFACTURED 
COMPANY 
1 Dexamethasone 
Sigma Aldrich life 
sciences, Bangalore 
2 glipinclamide 
Titan biotech limited, 
Bhiwadi 
3 Heparin sodium injection I.P 
Biological E. Limited, 
Hydarabad 
4 Sodium lauryalsulphate (L.R) Molychem, Mumbai 
5 Acetic acid(L.R) 
Thermo fisher scientific 
pvt.ltd Mumbai 
6 Thiobarbicturic acid (L.R) 
Hi Media Laboratories 
pvt.Ltd. Mumbai 
7 Tri chloro acetic acid (L.R) Molychem, Mumbai 
8 Phosphate buffer (K2HPO4) (L.R) 
Titan biotech limited, 
Bhiwadi 
9 
5,5
1
-dithiobis(2-nitrobenzoic 
acid) 99% extra pure(L.R) Kemphosol Bombay 
10 Sulphosalicylic acid (L.R) 
Burgoyne Burbidges& co 
Mumbai 
11 
Sodium pyro phosphate di basic 
(L.R) 
Sigma Aldrich life 
sciences, Bangalore 
12 PhenazineMethosulphate (R & D) 
Sigma Aldrich life 
sciences, Bangalore 
13 Nitro blue tetrazolium (L.R) Molychem, Mumbai 
14 
Coomassie brilliant blue 
(Bradford Reagent) (R & D) 
Sigma Aldrich life 
sciences, Bangalore 
15 Ethanol absolute (L.R) 
Changshuyanguan 
Chemical, China 
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16 Sodium Phosphate dibasic (L.R) 
Sigma Aldrich Life 
sciences, Bangalore 
17 
Potassium phosphate mono basic 
(R & D) Sigma Aldrich, Bangalore 
18 Ortho-phosphoric acid (L.R) 
Universal Laboratory pvt 
limited, Mumbai 
19 Pyridine (L.R) 
Merck Specialitiespvtlimt 
Mumbai 
20 Sodium chloride (L.R) Molychem, Mumbai 
21 Sodium citrate purified (L.R) 
S d Fine-chem limited, 
Mumbai 
22 NADH (R&D) 
Sigma Aldrich life 
sciences, Bangalore 
23 n-Butanol (L.R) 
Karnataka Fine Chem, 
Bangalore 
24 Sodium nitrite (L.R) 
S d Fine-chem limited, 
Mumbai 
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5.5 Extraction and Identification of Phytoconstituents  
5.5.1 Extraction of plant material 
The air dried Roots of Anisomeles malabarica Linn., 500gms each 
were coarse powdered and extracted with ethyl alcohol. The crude extract 
was further filtered and evaporated by the aid of rotary evaporator. The 
final mass is weighed and preserved for further use.   
5.5.2 Preliminary phytochemical screening 
Preliminary phytoconstituents present in the hydroethanolic extract 
of Anisomeles malabarica (L.) and Echinops echinatus Roxb., plants were 
identified based on the chemical test. 
1. Test for alkaloids  
Treated with dilute Hydrochloric acid and filtered. The filtrate was treated 
with various alkaloidal agents. 
a) Mayer’s–Test  
Treated with Mayer’s reagent and cream colour indicates the 
presence of alkaloid. 
b) Dragendroff’s–Test 
When little amount of the sample was treated with the 
Dragendroff’s reagent, the presence of reddish brown precipitate 
reveals the presence of alkaloid. 
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c) Hager’s–Test  
Treated with the Hager’s reagent and presence of yellow colour 
precipitate indicates the presence of alkaloid. 
d) Wagner’s–Test 
Treated with the Wagner’s reagent, the appearance of brown colour 
precipitate indicates the presence of alkaloid. 
2. Test for carbohydrates  
The extracts were treated with 3ml of alpha–Napthol in alcohol and to the 
sides of the test tube concentrated sulphuric acid was added carefully. 
Formation of violet colour ring at the junction of two liquids shows the 
presence of carbohydrates.  
a) Fehling’s–Test  
The extracts were treated with Fehling’s solution A and B and 
heated. Presence of reddish brown colour precipitate indicates the 
presence of reducing sugars. 
b) Benedict’s–Test  
The extracts were treated with Benedict’s reagent and heated and 
presence of reddish orange colour precipitate indicates the presence 
of reducing sugars. 
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c) Barfoed’s–Test  
The extracts were treated with Barfoed’s reagent and heated. 
Appearance of reddish orange colour precipitate indicates the 
presence of non reducing sugars. 
3. Test for proteins  
a) Biuret’s–test  
When the extracts were treated with copper sulphate solution, 
followed by the addition of sodium hydroxide solution, appearance 
of violet colour indicates the presence of proteins 
b) Millon’s–Test  
When the extract was treated with Millon’s reagent, appearance of 
pink colour indicates the presence of proteins. 
4. Test for steroids  
a) Libermann Burchard Test  
When the extracts were treated with concentrated sulphuric acid, 
few drops of glacial acetic acid, followed by the addition of acetic 
anhydride, appearance of green colour indicates the presence of 
steroids. 
5. Test for sterols  
When the extracts were treated with 5% potassium hydroxide solution, 
appearance of pink colour indicates the presence of sterols. 
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6. Test for phenols  
When the extracts were treated with neutral ferric chloride solution, 
appearance of violet colour indicates the presence of phenols. When the 
extracts were treated with 10% sodium chloride solution, the appearance 
of cream colour indicates the presence of phenols. 
7. Test for tannins  
a) When the extracts were treated with 10% lead acetate solution, 
appearance of white precipitate indicates the presence of tannins. 
b) When the extracts were treated with aqueous bromine solution, 
appearance of white precipitate indicates the presence of tannins. 
8. Test for flavanoids  
a) 5ml of the extract solution was hydrolyzed with 10 % v/v sulphuric 
acid and cooled. Then, it was extracted with diethyl ether and 
divided into three portions in three separate test tubes. 1 ml of 
diluted sodium carbonate, 1 ml of 0.1N sodium hydroxide, and 1ml 
of strong ammonia solution were added to the first, second and third 
test tubes respectively. In each test tube, development of yellow 
color demonstrated the presence of flavonoids. 
b) Shinoda's test  
The extract was dissolved in alcohol, to that one piece of magnesium 
followed by concentrated HCl was added drop wise and heated. 
Appearance of magenta color shows the presence of flavonoids. 
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9. Test for gums and mucilage  
The extracts were treated with 25ml of absolute alcohol, and then 
solution was filtered. The filtrate was examined for its swelling 
properties. 
10. Test for glycosides  
When a pinch of the extracts were dissolved in the glacial acetic 
acid and few drops of ferric chloride solution was added, followed 
by the addition of concentrated sulphuric acid, formation of red ring 
at the junction of two liquids indicates the presence of glycosides. 
11. Test for saponins  
Foam test 
1ml of the extracts are diluted to 20 ml with distilled water and 
shaken well in a test tube. The formation of foam in the upper part 
of the test tube indicates the presence of saponins. 
12. Test for terpenes  
When the extracts were treated with tin and thionyl Chloride, 
appearance of pink colour indicates the presence of terpenes. 
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5.6  TOXICITY STUDY 
5.6.1 Acute oral toxicity study (OECD 423) 
For carrying out oral toxicity study OECD guidelines 423 was 
followed.  It is a stepwise procedure with three animals of a single sex per 
step.  Depending on the mortality and/or, 50, 300, 2000mg/kg body weight) 
and the results allow a substance to be ranked morbidity of the animals a 
few steps may be necessary to judge the toxicity of the test substance.  This 
procedure has advantage over other methods because of minimal usage of 
animals while allowing for acceptable data. 
The method uses defined doses (5and classified according to the 
globally harmonized system. The starting dose for ethanolic extract was 
2000mg/kg bodyweight (p.o).  The dose was administered to the rats which 
were fasted overnight with water ad libitum and observed for signs of 
toxicity.  The same dose was once again tried with another three rats and 
were observed for 72 hours for symptoms like change in skin colour, 
salivation, diarrhea, sleep, tremors, convulsions and also respiratory,  
autonomic  and  CNS effects. 
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5.6.2  Sub acute toxicity study (OECD 407) 
For carrying out sub acute oral toxicity study OECD guidelines 
407 -Repeated Dose 28-Day oral toxicity study in rodents was followed.  
The duration of the Study was 28 days. Rat were administered with at 
the dose level of 200 mg/kg. Each group consists of ten animals (five 
animals/sex/group). The drug was administered orally once daily for 28 
days. On 29
th
 day the animals was anaesthetized and blood was collected 
by retro orbital puncture. Hematological parameters were evaluated. 
Serum was separated and biochemical parameters were estimated. 
Animals were sacrificed and organs were removed and weighed. The 
organs were kept in 10% formalin and used for histo-pathological 
analysis. 
Change in body weight 
The change in body weight was observed for a time period of 28 
days at an interval of 5 days. Body weight gains were determined from 
the final and initial body weights. 
Organ weight  
After sacrifice, organs were quickly excised and weighed and 
relative organ weights were computed.  
Hematological studies 
The following hematological parameters were estimated by 
standard procedures. 
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Blood samples were drawn by cardiac puncture and haematological 
parameters were analyzed by autoanalyzer.   
i. Total R.B.C. count 
ii. Total W.B.C. Count 
iii. Differential leukocyte count 
iv. Haemoglobin (Hb) concentration 
Biochemical studies 
Blood samples were drawn by cardiac puncture. Blood from three 
animals was pooled for serum separation. Each serum sample was 
analyzed by auto analyzer.   
i. Aspartate Aminotransferase (ASAT) 
ii. Alanine Aminotransferase (ALAT) 
iii. Alkaline Phosphatase (ALP) 
iv. Total Bilirubin (TB) 
v. Total protein. 
 
Histopathological study 
After blood collection rats were sacrificed for tissue studies. The 
internal organs like liver, kidney, lungs, brain and heart were isolated 
and blotted free of blood, weighed immediately to determine relative 
organs weights and observed for gross lesions. Histological examination 
was performed on the tissue preserved in 10% buffered formalin 
solution with particular emphasis on those which showed gross 
pathological changes. 
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5.7 EXPERIMENTAL DESIGN - ANTI DIABETIC 
Experimental Protoco 
30 Rats were divided in to 5 groups (n=6) and the duration of the 
experiment was 21 days with overnight fasting. 
Groups Treatment 
Group-I Rats received normal distilled water for 21 days. 
Group-II 
Rats received Dexamethasone 10 mg/kg i.p for a period of 
10 days 
Group –III 
Rats received Dexamethasone 10 mg/kg i.p with low dose 
of drug 100mg/kg p.o 
Group –IV 
Rats received Dexamethasone 10 mg/kg i.p with high dose 
of drug 200mg/kg p.o 
Group -V 
Rats received Dexamethasone 10 mg/kg i.p along with 
standard drug Glipenclamide 500mg/kg p.o 
 
At the end of the treatment period, rats were deprived of food overnight 
and sacrificed on day 22
nd
 day by light ether anesthesia followed by 
decapitation after recording the final body weight. Blood was collected 
from each rat for biochemical estimation and pancreas was quickly 
isolated immersed in ice cold saline and weighed.  Pancreas was stored 
under freezer (-20 °C) for estimation of tissue antioxidant parameters  
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5.7.1  Estimation of blood glucose: (GOD/POD Method) 
Span diagnostics kit was used for the estimation of serum/plasma 
glucose. The estimation was carried out by GOD/POD method. The 
enzyme glucose oxidase catalyses the oxidation of glucose to gluconic 
acid and hydrogen peroxide as follows: 
Glucose + O2 + H2o      
Glucose oxidase 
    Gluconic acid + H2o 
 
Addition of the enzyme peroxidase and a chromogen such as 4 
Aminoantipyrine results in the formation of a colored compound 
quinoneimine that can be measured. 
2H20 + 4-Aminoantipyrine phenol    
peroxidase
       Quinonimine + 4H2o 
The red color of quinoneimine is measured at 505 nm and is directly 
proportional to glucose concentration. 
Glucose oxidase is highly specific for β – D glucose because 36% and 
64% of glucose in solution are in alpha and beta forms respectively, 
complete reaction requires mutarotation of the α to β form . The second 
step, involving peroxidase, is much specific than the glucose oxidase 
reaction. Various substances, such as uric acid, ascorbic acid, bilirubin,   
hemoglobin, tetracycline and glutathione, inhibit the reaction 
(presumably by competing with chromogen for H2O2) producing lower 
values. Some glucose oxidase preparations contain Catalase as a 
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contaminant; Catalase activity decomposes peroxide and decreases the 
intensity of the final color obtained. 
Programme: 
The basic assay parameters  
Mode  End point 
Wavelength 505 nm (490 – 550 nm) 
Temperature 37 
o 
C or R.T. 
Optical path length 1 cm 
Blanking Reagent blank 
Incubation time ( minutes) 10 at 37 
o 
C or 30 at R.T. 
Sample volume  10 μl 
Working reagent volume  1000 μl  
Concentration of standard  100 mg/dL 
Linearity Upto 5oo mg/dL 
Stability of color  1 hour 
Maximum absorbance limit 2.000 
Units  mg/dL 
 
Procedure: 
Pipette into tubes marked Blank Standard Test 
Serum or Plasma  - - 10 μl 
Glucose standard  - 10μl - 
Working glucose reagent 1000 μl 1000μl 1000μl 
The above were mixed well , incubated at 37 
o 
C  for 10 min or R.T. for 
30 min and the absorbance of sample (As) and of standard (Astd) was 
read against blank. 
Calculation:  
                       Glucose (mg/dL) = (As / Astd) x concentration of the standard 
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5.7.2 Estimation of serum cholesterol 
Span diagnostics kit was used for the estimation of serum cholesterol. 
Method: 
Enzymatic, (Cholesterol Oxidase – Peroxidase), Endpoint colorimetry.  
Single Reagent Chemistry, with LCF (Lipid clearing factor) 
Principle: 
The estimation of cholesterol involves the following enzymatic reactions  
Cholesterol esters             
CE
           Cholesterol + Fstty acids  
Cholesterol + 02                      
CO
                 Cholesten – 3 – one + H2o  
H2o2 + Phenol + 4-APP     
POD
       Quinoneimine dye + H2o 
CE = Cholesterol esterase  
CO = Cholesterol oxidase  
POD = Peroxidase  
4APP=4-Aminoantipyrine  
Absorbance of quinoneimine was measured at 505nm which 
proportional to cholesterol Concentration in the specimen. 
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Programme: 
The basic assay parameters are: 
Mode End point 
Wavelength 505 nm (490 – 550 nm) 
Temperature  37
 o 
C 
Optical path Length 1 cm  
Blanking  Reagent Blank 
Incubation time ( minutes) 10 at 37 
o 
C 
Sample volume  10 μl 
Working reagent volume  1000μl 
Concentration of standard 200 mg/dL 
Linearity  750 mg/dL 
Stability of color 1 hour  
Maximum absorbance limit 2.000 
Units  mg/dL 
 
Procedure: 
 
Pipette into tubes 
marked 
 
Blank 
 
Standard 
 
Test 
Serum - - 10μl 
Standard - - - 
Cholesterol Reagent 1000μl 1000μl 1000μl 
The above were mixed well, incubated at 37 
o 
C for 10 minutes, the 
absorbance of standard and sample were read against reagent blank at 
505 nm within 60 minutes . 
Calculation: 
          Cholesterol concentration (mg/dL) = Absorbance of test          x   200 
                                                                  Absorbance of standard 
 
           Cholesterol concentration (mmol/L) = concentration (mg/dl) x 0.0259 
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5.7.3 Estimation of serum triglycerides 
Span diagnostics kit was employed for the assessment of serum TG. 
Method: 
Enzymatic (GPO/Trinder), Endpoint Colorimetry, Single Reagent 
Chemistry with LCF (Lipid Clearing Factor) 
Principle: 
The estimation of triglycerides involves the following enzymatic 
reaction: 
Glycerol +         
LPL
         Glycerol + FFA 
Glycerol + ATP     
GK
           Glycerol – 3 – Phosphate + ADP 
Glycerol – 3 – Phosphate + o2        
GPO
        DHAP + H2O2 
2H2O2 + 4 APP      
POD
       Quinoneimine dye + 4 H2o 
  Absorbance of the quinoneimine dye measured at 550 nm 
is increased with increase in the triglycerides concentration. 
Programme: 
The basic assay parameters 
 
Procedure; 
The above were mixed well, incubated at 37 
o 
C for 10 minutes, the 
absorbance of standard and sample were read against blank at 505 nm 
within 60 minutes. 
Mode Endpoint 
Wavelength 505 nm (490 – 550 nm) 
Temperature 37 
o 
C 
Optical path length 1 cm 
Blanking Reagent Blank 
Incubation time ( minutes) 10 at 37 
o 
C 
Sample Volume 10 μl 
Working reagent Volume 1000 mg/dL 
Concentration of standard 200 mg/dL 
Linearity 1000mg/dL 
Stability of color 1 hour 
Maximum absorbance limit 2.000 
Units mg/dL 
Pipette into tubes 
marked 
Blank Standard Test 
Serum or Plasma - - 10 μl 
Glucose Standard - 10μl - 
Triglycerides Reagent 1000μl 1000μl 1000μl 
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Calculation: 
                 Triglycerides (mg/dL) = Absorbance of test    x 200 
                                                       Absorbance of standard  
                 Triglycerides (mmol/L) = Concentration (mg/dL) x 0.014 
 
5.7.4 Estimation of serum HDL-Cholesterol and LDL-Cholesterol 
S.D Kit was employed for the assessment of serum HDL – cholesterol. 
Method: 
Polyethylene glycol – CHOD – PAP Endpoint Colorimetry. Two – 
Reagent Chemistry with LCF (Lipid clearing Factor) 
Principle:     
Low and Very low density lipoproteins (LDL and VLDL) are resulted 
out by adding a supplementary poly ethylene glycol 6000. Iin this 
procedure the HDL are sorted out. HDL Cholesterol is predictable by 
separating the upper layer and also by observing the sequence of 
enzymatic reactions starting from the conversion of cholesterol to 
cholestenone catalysed by cholesterol oxidase in the oxidation process 
and also by the creation of H 2 O 2  figure out a red tinted quinoneimine . 
Absorbance 505 nm is increased with increasing HDL Cholesterol 
incidence. 
Procedure:    
STEP – A: HDL – CHOLESTEROL SEPERATION 
Pipette into Centrifuge tube Quantity 
Sample 
Precipitating reagent 
0.2 ml 
0.2ml 
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The above were mixed well, kept at R. T. and then centrifuged at 2000 
rpm for some time and then centrifuged at 2000 rpm for 15 minutes to 
attain a apparent upper layer and then continued to step – B 
Step – B Colour Development: 
The above were mixed well, incubated at 37 
o 
C for some time and 
absorbance was spectrophotometrically for reagent adjacent to blank at 
505 nm within 1hour. 
Programme: 
The basic assay parameters 
 
Calculation: 
 
                  HDL Cholesterol (mg/dL) =     Absorbance of Test      x 50 x 2 
                                                                  Absorbance of Standard 
 
 
Pipette into tubes manifest Blank Standard Test 
Supernatant from step A - - 100μl 
HDL Cholesterol Standard            -           100μl               -  
Cholesterol Reagent      1000μL          
1000μL 
        1000μL 
Mode End Point 
Wavelength 505 nm (490 – 530 nm) 
Temperature 37
 o 
C or R.T. 
Optical path Length 1 cm 
Blanking Reagent Blank 
Incubation time ( minutes) 10 at 37 
o 
C or 30 at R.T. 
Sample volume 100μl 
Working reagent volume 1000μl 
Concentration of standard 50 mg/dL 
Stability of color 1 hour 
Maximum absorbance limit 2.000 
Units mg/dL 
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5.8 Evaluation of antioxidant status 
5.8.1Estimation of TBARS
  
TBARS levels were determined by a modified version of the method 
described by Ohkawa. 
Principle  
Acetic acid was used to detach the lipid and protein of the tissue and the 
protein in the reaction mixture were dissolved by the addition of sodium 
lauryl sulphate. Thiobarbituric acid reacts with lipid peroxides, 
hydroperoxide and oxygen double bond to form a coloured adduct with 
absorption maximum at 532 nm, which was then measured.  
Reagents  
Sodium lauryl sulphate  -  8.1% (W/V)  
Acetic acid      - 20% (pH – 3.5)  
Thiobarbituricacid   -  0.8% (w/v)  
Butanol:Pyridine     -  (15:1) (v/v)  
Trichloracetic acid (TCA) -  10%  
Procedure  
Liver was homogenized with 2 ml of Trichloroacetic acid (TCA). 0.2 ml 
of whole homogenate was taken to which 0.2 ml of 8.1% sodium lauryl 
sulfate, 1.5 ml of 20% acetic acid and 1.5 ml 0.8% thiobarbituric acid 
were added. Volume was made up to 4 ml with double distilled water. It 
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was heated at 95°C for 60 min. After cooling, 1 ml of double distilled 
H2O and 5 ml of butanol– pyridine mixture was added. The solution 
was shaken vigorously in a vortex and centrifuged at 4000 rpm for 10 
min in a cold centrifuge. The organic layer was separated and 
absorbance was observed at 532 nm in a spectrophotometer.  
Standard curve  
Various concentrations of 1, 1, 3, 3-Tetra methoxy propane (TMP) were 
used as external standard (1–10 nm) and were subjected to the steps 
mentioned in the procedure section. The readings of absorbance were 
plotted against the concentration of TMP to derive a linear standard 
graph. Data expressed as nmole/g wet wt. tissue  
Calculation  
The concentration of TBARS was determined from the linear standard 
graph.  
5.8.2 Glutathione [GSH] 
Glutathione was estimated by the method described by Ellman 
Principle   
Bis (p-nitro phenyl) disulphide reacts with aliphatic thiol compounds at 
pH 8.0 to produce one mole of p-nitrothiophenol anion per mole thiol.  
Since this anion is highly coloured (λm ≈ 13, 6000 at 412 nm), it can be 
used to measure the thiol concentration.  
Reagents  
Phosphate buffer (K2HPO4)    - 0.3 M (pH-8.4)  
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5, 5` - Dithiobis (2- nitrobenzoic acid) - 0.2% w/v (DTNB)  
Sulfosalicyclic acid      -10% v/v  
Procedure   
The Liver were homogenized with 10% TCA and centrifuged at 3000 × 
g for 10 min. The reaction mixture contained 0.1 ml of supernatant, 2.0 
ml of 0.3 M phosphate buffer (pH-8.4), 0.4 ml of double distilled water 
and 0.5 ml of DTNB [5, 5dithiobis (2-nitrobenzoic acid)]. The reaction 
mixture was incubated for 10 min and the absorbance was measured at 
412 nm in a spectrophotometer.  
Standard Curve  
Various concentrations of the standard glutathione (1–10 µg) were 
subjected to the steps mentioned above. The readings of absorbance 
were plotted against the concentration of GSH to produce a linear 
standard graph.  
Calculation  
The concentration of GSH was determined from the linear standard 
graph. Data are expressed as µmole per gm wet weight.   
5.8.3 Estimation of SOD 
SOD levels in the hearts were determined by the method of McCord and 
Firdovich method (1969) and modified by Kakkar 
Principle  
Superoxide anions were generated in a system comprising of NADH and 
phenazinemethosulphate. This superoxide anion reduced into blue 
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tetrazolium forming a blue Formozan, which was measured at 560 nm. 
SOD inhibited the reduction of nitrobluetetrazolium and thus the 
enzyme activity was measured by monitoring the rate of decrease in 
optical density at 560 nm. 
Reagents  
Sodium pyrophosphate   - 0.052 M, pH 8.3   
Phenazinemethosulphate  - 186 mM 
Nitrobluetetrazolium   - 300 mM 
Glacial acetic acid    - 60.05 M   
Tris buffer with sucrose    - 0.25 M   
Tris HCL buffer     - 0.0025 M, pH 7.4  
Procedure  
The Liver was homogenized in 0.25 M Tris–sucrose buffer. Then the 
homogenized liver was centrifuged at 10,000 rpm for 15 min at 4°C. 
The supernatant was collected, to which 50% ammonium sulphate was 
added, vortexes, and the reaction mixture was kept for incubation at 4°C 
for 4 h. After the incubation period it was again centrifuged at 12,000 
rpm for 30 min at 4°C. The samples were then kept overnight for 
dialysis in 0.0025 TrisHCl buffer.  
The next day, appropriate volumes of samples to a maximum of 1.2 ml 
were taken. To it, 1.2ml sodium pyrophosphate, 0.1 ml of 
phenazinemethosulphate, 0.3 ml of NBT and 0.2 ml NADH were added. 
The final volume was made up to 3 ml with distilled water. After adding 
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NADH, it was immediately incubated for 90 sec at 30°C and the 
reaction was stopped by adding 1ml acetic acid to the reaction mixture. 
4 ml of butanol was added and after 10 min, centrifuged at 3000 rpm, 
for 10 min. The organic layer was separated and absorbance was 
observed at 560 nm in a spectrophotometer.  
Standard curve  
Various concentrations of standard SOD (0.1 to 2.0 µg) were subjected 
to the same steps as the samples mentioned in the above procedure. The 
reading of absorbance was plotted against the concentrations of SOD to 
derive a linear standard graph.  
Calculation  
The concentration of SOD was determined from the linear standard 
graph. Data expressed as IU/mg protein.  
5.8.4 Estimation of Catalase 
Principle  
In the ultraviolet range, H2O2 shows a continual increase in absorption 
with decreasing wavelength. The decomposition of H2O2 can be 
followed directly by the decrease in extinction at 240 nm. The difference 
in extinction at 240 nm was measured. The difference in extinction per 
unit time is a measure of the catalase activity.  
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Reagents  
Phosphate buffer - 50 mM at pH 7.0 (0.05 M KH2PO4) and 0.053M 
Na2HPO4 mixed in a ratio of 1:1.55  
Hydrogen peroxide - 30 mM solution Isotonic buffer   - pH 7.4 (0.9% 
NaCl and 0.01 M phosphate buffer)  
Ethanol - 99.99%  
Triton X - 10%  
Procedure  
The liver was homogenized with isotonic buffer and centrifuged at 3000 
rpm for 10 min. The supernatant liquid was collected and 0.01 ml of 
ethanol per ml of supernatant liquid was added. Then the samples were 
incubated for 30 min in an ice water bath. At the end of the incubation 
period, 10% Triton X was added to 0.1/ml of supernatant and used for 
catalase estimation. 2 ml of sample was appropriately diluted in 
phosphate buffer and 1 ml H2O2 was added and extinction was read at 
240 nm at 15 sec interval for a total of 30 sec. Standard curve Various 
concentrations of standard catalase (1–20 µg) were subjected to the steps 
mentioned above. The readings of absorbance were plotted against the 
concentrations of catalase to derive a linear standard graph. 
Calculation.The concentrations of catalase in the samples were 
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determined from the linear standard graph. Data expressed as IU/mg 
protein.  
5.9 Statistical analysis 
All the data was expressed as mean ± SEM. Statistical significance 
between more than two groups was tested using one way ANOVA 
followed by the Dunnett's Multiple Comparison testusing computer 
based fitting program (Prism, Graph pad.). Statistical significance was 
determined at P < 0.0001 
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VI. RESULTS AND ANALYSIS 
6.1 The percentage yield of ethanolic extracts of roots of Anisomeles 
malabarica (L.) was 16%. 
6.2 Preliminary phytochemical tests  
Table:- 4 shows the phytochemical analysis of ethanolic extract of  
Anisomeles malabarica(L.) revealed the presence of alkaloid, glycoside, 
sterols, phenols, tannins, flavanoids, terpenes, saponins, flavonoids, 
tannins, carbohydrates, proteins, phenolic compounds, and phytosterols.  
Preliminary Phytochemical Screening of ethanolic extract of 
Anisomeles malabarica(L.) 
  
 -ve- indicate the absence of compound  
 +ve- indicate the presence of compound 
S.NO Constituents 
ETHANOLIC  
EXTRACT  
1 Alkaloids 
Mayer’s Test  +ve 
Dragendroff’s Test  +ve 
Hager’s Test  +ve 
Wagner’s Test  +ve 
2 Carbohydrates 
Fehling’s Test -ve 
Benedict’s Test  +ve 
Barfoed’s Test  +ve 
3 Proteins 
Biuret’s test  +ve 
Millon’s Test  -ve 
4 Steroids Libermann Burchard Test -ve 
5 Sterols  -ve 
6 Phenols  +ve 
7 Tannins  +ve 
8 Flavonoids  +ve 
9 Gums and Mucilage  -ve 
10 Glycosides  +ve 
11 Saponins Foam test +ve 
12 Terpenes  -ve 
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6.3.1 Acute Toxicity studies of ethanolic extract of the plant 
Anisomeles malabarica(L.) 
Parameters observed  I
st
  hr II
nd
  hr III
rd
 hr IV
th 
hr 
Aggressiveness + + + + 
Alertness - - - - 
Alopecia  - - - - 
Circling  - - - - 
Diarrhoea - - - - 
Edema - - - - 
Eye closure at touch  + + + + 
Grip strength + + + + 
Grooming  + + + + 
Lacrimation - - - - 
Loss of writing reflex - - - - 
Mortality - - - - 
Nasal sniffing  - - - - 
Piloerection - - - - 
Rearing  - - - - 
Righting reflex - - - - 
Seizures - - - - 
Straub tail - - - - 
Urine stains  - - - - 
 
4 hours observation in acute toxicity studies of 2000mg/kg of 
Anisomeles malabarica (L.) 
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Parameters 
observed  
Day-
1 
Day-
2 
Day-
3 
Day-
4 
Day-
5 
Day-
6 
Day-
7 
Day-
8 
Day-
9 
Day-
10 
Day-
11 
Day-
12 
Day-
13 
Day-
14 
Aggressiveness + + + + + + + + + + + + + + 
Alertness - - - - - - - - - - - - - - 
Alopecia  - - - - - - - - - - - - - - 
Circling  - - - - - - - - - - - - - - 
Diarrhoea - - - - - - - - - - - - - - 
Edema - - - - - - - - - - - - - - 
Eye closure at 
touch  
+ + + + + + + + + + + + + + 
Grip strength + + + + + + + + + + + + + + 
Grooming  + + + + + + + + + + + + + + 
Lacrimation - - - - - - - - - - - - - - 
Loss of writing 
reflex 
- - - - - - - - - - - - - - 
Mortality  - - - - - - - - - - - - - - 
Nasal sniffing  - - - - - - - - - - - - - - 
Piloerection - - - - - - - - - - - - - - 
Rearing  - - - - - - - - - - - - - - 
Righting reflex - - - - - - - - - - - - - - 
Seizures - - - - - - - - - - - - - - 
Straub tail - - - - - - - - - - - - - - 
Urine stains  - - - - - - - - - - - - - - 
 
6.3.2 Observation in acute toxicity studies at the dose of 2000mg/kg bw p.o dose of Anisomeles malabarica (L.)
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I. SUB-ACUTE TOXICITY STUDIES 
 
Sub-acute toxicity studies were carried out according to OECD 407 and rats were divided into groups of 10 animals (5 male and 5 female). 
The suspension of ethanolic extract was administered to rats at the dose of 100 & 200 mg/kg/day for 28 days. The toxic symptoms such as 
signs of toxicity, mortality and body weight changes were monitored. Rats were anesthetized with ether at the end of the treatment period. 
All rats were sacrificed after the blood collection. 
6.3.3 Signs of toxicity in sub acute toxicity (28 days) 
Parameters observed  
Day-2 Day-4 Day-6 Day-8 Day-
10 
Day-
12 
Day-
14 
Day-
16 
Day-
18 
Day-20 Day-22 Day-24 Day-26 Day-28 
Aggressiveness + + + + + + + + + + + + + + 
Alertness - - - - - - - - - - - - - - 
Alopecia  - - - - - - - - - - - - - - 
Circling  - - - - - - - - - - - - - - 
Diarrhoea - - - - - - - - - - - - - - 
Edema - - - - - - - - - - - - - - 
Eye closure at touch  + + + + + + + + + + + + + + 
Grip strength + + + + + + + + + + + + + + 
Grooming  + + + + + + + + + + + + + + 
Lacrimation - - - - - - - - - - - - - - 
Loss of writing 
reflex 
- - - - - - - - - - - - - - 
Mortality  - - - - - - - - - - - - - - 
Nasal sniffing  - - - - - - - - - - - - - - 
Piloerection - - - - - - - - - - - - - - 
Rearing  - - - - - - - - - - - - - - 
Righting reflex - - - - - - - - - - - - - - 
Seizures - - - - - - - - - - - - - - 
Straub tail - - - - - - - - - - - - - - 
Urine stains  - - - - - - - - - - - - - - 
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Treatment 0th day 5th day 10th  day 15st day 20th day 25th day 28th day % increase 
Control 175.83±6.84 179.50±6.28 181.83±6.46 184.83±6.31 187.16±6.01 190.66±6.46 193.66±5.70 10.3637 
100mg/kg 177.00±4.43 180.50±4.47 182.83±5.02 186.16±5.40 190.00±6.04 192.500±5.70 195.500±5.63 10.1695 
200mg/kg 177.16±8.02 178.83±8.17 182.83±8.23 186.00±7.85 189.000±8.11 192.16±8.43 194.83±8.34 09.6044 
 
6.3.4 Change in body weight after the drug treatment Anisomeles malabarica(L.) 
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6.3.5  Haematological Parameter  
 
Haematological parameter 
 
Control 
Anisomeles malabarica (L.) 
100 mg 200mg 
Total R.B.C. count (×10
6
 
mm−3). 
9.09±0.15 8.90±0.12 9.11±0.16 
Total W.B.C. Count (×10
3
 
mm−3). 
12.67±0.22 12.35±0.15 11.23±0.23 
Haemoglobin (Hb) (g/dl) 15.61±0.36 14.07±0.30 15.63±0.36 
Hematocrit (%). 44.21±1.01 43.61± 1.72 36.4±1.36 
Platelets (×103 mm−3). 834.91±24.01 867.21±23.25 739.81±26.86 
Lymphocytes(%). 84.7±1.32 81.8±1.33 72.8±1.43 
Neutrophils (%). 20.6±0.65 12.6±0.52 19.2±0.91 
 
Data are expressed as mean ± SEM 
 
6.3.6  Biochemical Parameters  
 
Biochemical parameter 
 
Control 
Anisomeles malabarica (L.) 
100 mg 200mg  
Creatinine (mg/dl) 0.5890±0.079 0.6600 ±  0.049 0.5540 ±  
0.074 
Urea (mg/dl) 15.30 ± 0.47 14.50 ± 0.40 15.20 ±0.57 
Triglycerides (mg/dl) 52.20±1.13 51.40±1.08 47.10±1.62 
Total Cholesterol (mg/dl) 46.60±1.21 51.40±1.08 54.03±1.67 
Total protein (mg/dl) 4.40±0.26 4.20±0.35 3.70±0.26 
Albumin (g/dl) 3.20±0.41 3.70±0.33 3.20±0.29 
AST (IU/L) 121.41±2.68 121.3±1.65 116.61±2.045 
ALT (IU/L) 69.40±1.57 67.60±1.301 68.60±1.108 
ALP (IU/L) 112.6±4.67 117.01±0.714 117.41±0.718 
T. Bilirubin (mg/dl) 0.2569±0.32 0.267±0.029 0.254±0.023 
 
Data are expressed as mean ± SEM 
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6.4 HISTOPATHOLOGY OF VITAL ORGANS  
At the end of the 30th day Liver, Kidney, Heart, Lungs and Brain were 
subjected for routine Histopathological examination and fixed in 10 % formal 
saline (10 parts of formaldehyde and 30 parts of normal saline). Tissues were 
processed and embedded in paraffin wax. Sections were cut at 5 micron thickness 
and stained with Haematoxylin and Eosin. Light microscopic examination of the 
sections was then carried out and micrographs produced using Vanox-T Olympus 
photographing microscope. The histopathological examinations were reviewed by 
the pathologist. 
 
BRAIN          
  
100mg/kg 
 
Control  
 
HEART   
  
100mg/kg Control 
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KIDNEY  
  
100mg/kg Control 
     
LIVER  
  
100mg/kg Control 
        
LUNG  
  
100mg/kg Control 
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6.5  Dexamethasone induced diabetic model 
Blood was collected from each rat for biochemical estimation and pancreas 
was quickly isolated immersed in ice cold saline and weighed. Pancreas was 
stored under freezer (-20 °C) for estimation of tissue antioxidant parameters. 
5.2 Effect of Anisomeles malabarica Linn on serum biochemical parameters 
Blood glucose, Total cholesterol, HDL, LDL, VLDL, Triglycerides, levels 
were estimated in serum. The results were presented. 
6.5.1 Serum level of Blood glucose  
There is significant (P<0.0001) increase in the level of Blood glucose at 
group 2 when compared with Group 1. There is significant (P<0.001) decrease in 
the level of Blood glucose at group 3, 4 and 5 when Compared with group 2. 
 
 
 
 
 
 
6.1. Effect of Anisomeles malabarica Linn on blood glucose levels  
 
 
G1-Normal group 
G2- 
G3-AM (100mg/kg) 
G4-AM (200mg/kg) 
G5-Glibinclamide 
(500mg/kg) 
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6.5.2 Serum level of Total cholesterol 
 There is no significant increase in the level of Total cholesterol at group 2 
when compared with group 1. There is significant increase (P<0.001) in the level 
of Total cholesterol at group 3 when compared to group 2. Group 4 showed 
significant increase (P<0.0001) in the level of Total cholesterol compared to group 
2. There is significant (p<0.001) increase in the level of Total cholesterol in group 
5 compared to group 2. 
 
 
 
 
 
5.2. Effect of Anisomeles malabarica Linn on Total cholesterol levels  
 
6.5.3 Effect of Anisomeles malabarica Linn on HDL  
There is significance (p<0.01) increase in the level of ALP at group 2 when 
compared with group 1. There is significant (p<0.0001) decrease in the level of 
ALP at group 3 when compared to group 2. There is significance (p<0.01) 
increase in the level of ALP at group 4 when compared to group 2. There is no 
significance increase in the level of ALP at group 5 when compared to group 2. 
 
G1-Normal group 
G2-Toxic group 
G3-AM (100mg/kg) 
G4-AM (20mg/kg) 
G5-Glibinclamide 
(500mg/kg) 
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6.5.4 Serum level of HDL 
 
 
 
 
 
 
 
Serum level of LDL 
6.5.5 Serum level of LDL 
There is no significance increase in the level of LDL at group 2 when 
compared with group 1. There is significant increase (p<0.0001) in the level of 
LDL at group 3 when compared to group 2. There is significance (p<0.01) 
increase in the level of LDL at group 4, when compared to group 2. There is 
significance (p<0.0001) increase in the level of LDL at group 5 when compared to 
group 2. 
 
 
 
 
  
G1-Normal group 
G2-Toxic group 
G3-AM (100mg/kg) 
G4-AM (20mg/kg) 
G5-Glibinclamide 
(500mg/kg) 
 
G1-Normal group 
G2-Toxic group 
G3-AM (100mg/kg) 
G4-AM (20mg/kg) 
G5-Glibinclamide 
(500mg/kg) 
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6.5.6 Serum level of VLDL 
There is no significance increase in the level of VLDL at group 2 when 
compared with group 1. There is significant (p<0.0001) increase in the level of 
VLDL at group 3, 4 and 5 when compared with group 2. 
 
 
Graph 5.5. Effect of Anisomeles malabarica Linn on VLDL level 
 
 
 
6.5.7 Serum level of Triglycerides 
 
 
 
 
 
 
There is no significance increase in the level of Triglycerides at group 2 when 
compared with group 1. There is significant (p<0.0001) increase in the level of 
cholesterol at group 3, 4 and 5 when compared with group 2. 
 
 
G1-Normal group 
G2-Toxic group 
G3-AM (100mg/kg) 
G4-AM (20mg/kg) 
G5-Glibinclamide 
(500mg/kg) 
 
G1-Normal group 
G2-Toxic group 
G3-AM (100mg/kg) 
G4-AM (20mg/kg) 
G5-Glibinclamide 
(500mg/kg) 
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6.6 Effect of Anisomeles malabarica Linn on tissue parameters 
Pancreas are homogenised and TBARS, GSH, SOD, Catalase, levels were 
estimated. The results were presented in Table 5.5 and Graph no. 5.4, 5.5 and 5.6 
6.6.1 Effect on TBARS 
There is significance (P<0.0001) increase in the level of TBARS at group 2 
when compared with group1. There is significance (P<0.01) decrease in the level 
of TBARS at group 3, 4, and5 when compared with group 2. 
 
 
 
 
 
 
 
 
 
Effect of Anisomeles malabarica Linn on TBARS levels 
 
6.6.2 Effect on reduced glutathione (GSH) 
There is significance decrease in the level of GSH at group 2 when compared to 
group 1. There is significance (P<0.0001) increase in the level of GSH at group 3 
when compared to group 2. There is significance (P<0.0001) increase level of 
GSH at group 4, 5 when compared with group 2. 
 
 
 
 
 
 
 
Effect of Anisomeles malabarica Linn on GSH levels 
G1-Normal group 
G2-Toxic group 
G3-AM (100mg/kg) 
G4-AM (200mg/kg) 
G5-Glibinclamide 
G1-Normal group 
G2-Toxic group 
G3-AM (100mg/kg) 
G4-AM (200mg/kg) 
G5-Glibinclamide 
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6.6.3 Effect on superoxide dismutase (SOD) 
There is significance decrease in the level of SOD at group 2 when 
compared with group 1. There is significance (P<0.0001) increase in the level of 
SOD at group 3,4 and 5 when compared with group 2.  
 
 
 
 
 
 
 
 
 
Graph  5.10 Effect of Anisomeles malabarica Linn on SOD levels 
 
6.6.4 Effect on Catalase (CAT) 
There is significance decrease in the level of catalase at group 2 when 
compared to group 1. There is significance (p<0.0001) increase in the level of 
catalase at group 3 when compared with group 2. There is significance (P<0.0001) 
increase level of catalase at group 4, 5 when compared with group 2. 
 
 
 
 
 
 
 
Graph  5.11 Effect of Anisomeles malabarica Linn on Catalase 
Table no: 5.5Tissue level of Catalase, GSH, SOD, and TBARS 
 
G1-Normal group 
G2-Toxic group 
G3-AM (100mg/kg) 
G4-AM (20mg/kg) 
G5-Glibinclamide 
(500mg/kg) 
 
 
G1-Normal group 
G2-Toxic group 
G3-AM (100mg/kg) 
G4-AM (200mg/kg) 
G5-Glibinclamide 
(500mg/kg) 
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VII. DISCUSSION  
D.M. is a very common metabolic disorder affecting three fourth of the 
world’s population in advanced age and is the fourth leading causes of death in 
the world. The occurrence is very common and not in any one hands. Neither 
diet nor long term usage of medicines leads to this disease. They are only 
minor causes and major reason is only inheritance. Once affected there is no 
cure and is the major border line for many micro and macro vascular 
complications.  
The usage of carbohydrates, proteins and amino acids play a major role in 
our body as they are the major source to generate ATP for energy purpose. 
There is imbalance in this major metabolic process of carbohydrates which is 
linked to low insulin levels or insulin sensitivity in people affected with the 
disease. The energy fuel glucose shows imbalances in the disease causing 
hyperglycemia.  
Many allopathic drugs are there to be used as anti-diabetic agents to lessen 
the commonness of the disease as there is no permanent cure for the disease. 
But these allopathic medicines have equal side effects than the 
pharmacological effects. Hence the usage of these drugs can be replaced by 
using herbal drugs that don’t possess any side effects and sometimes the 
diseases can be cured permanently. But yet they have to be commercially 
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proved as modern medicines. Even though there are many anti diabetic agents, 
the research in finding herbal drugs for diabetes has not been stopped and is a 
continuous process because of intolerable adverse effects of allopathic 
medicines. 
     Glucocorticoids are broadly used therapeutic tools, mainly in treatment 
meant for anti-inflammatory as well as immunomodulatory purposes. 
Glucocorticoid treatment Side effects include steroid diabetes. Glucocorticoid 
shows hyperglycemia is partly owing to improved hepatic glucose production 
as well as insulin resistance of peripheral tissues. in addition, glucocorticoids 
are recognized to reduce insulin secretion. The primary mechanism involves 
increased α2- adrenoceptor signaling and enlarged Potassium channel activity 
and impaired glucose metabolism. even though reduced insulin secretion 
through glucocorticoid treatment can be overcome by stopping adrenoceptor 
signaling or by reduction of potassium channel convincing evidence suggests 
that the proper functioning of β-cells that’s depends on cell survival. Therefore, 
a reduction of β-cell mass in longstanding glucocorticoid therapy may give up 
the subsequent development of steroid diabetes 
Insulin resistances in humans are shown in situation like obesity, non-
insulin dependent diabetes mellitus (NIDDM) and Dyslipidemia. So, 
interventions to reduce insulin resistance might push back the development of 
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NIDDM and the complications. Treatment through natural herbs is probable to 
be filled with smaller side effects compared to the currently use synthetic oral 
anti diabetic agents. several medicinal plants encloses has been reported to 
posses considerable antidiabetic effect in both type 1 and II diabetes mellitus 
along with  improved glucose tolerance. Dexamethasone is a powerful 
synthetic element of the glucocorticoid group of steroid hormones. 
Dexamethasone administration leads to causes hyperglycemia, insulin 
resistance, and Dyslipidemia in human and experimental animals. Insulin 
resistance and hyperinsulinemia are often linked with a group of risk factors 
such as impaired glucose tolerance, obesity, hypertension and Dyslipidemia.  
Dexamethasone is an effective and greatly selective glucocorticoid used in 
the treatment of inflammation. Large exposure of glucocorticoids impairs 
insulin sensitivity, leads to the generation of metabolic syndrome as well as 
insulin resistance and hypertension. The mechanism which dexamethasone 
induces peripheral insulin resistance is in inhibiting GLUT-4 translocation, and 
rising lipase activity in adipose tissue leads to cause impairment of 
Endothelium-dependent vasodilatatio. Dexamethasone increases the 
triglycerides levels causing an difference in lipid metabolism leads to 
hyperlipidemia and increases glucose levels causes to hyperglycemia 
Pharmacological doses of glucocorticoids induces ob gene expression in rat 
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adipose tissue within 24 hrs and is followed by a complex metabolic changes 
ensuing in decrease in food consumption causing reduction in body weight and 
also occurred with  by diabetes and generation of Insulin resistance with 
improved glucose and triglycerides levels. In this experiment administration of 
dexamethasone for 10days resulted in improved glucose, triglycerides, 
cholesterol, insulin, levels. Anisomeles malabarica Linn at a dose of 10mg/kg 
and 20 mg/kg drastically prevented the rise in blood glucose levels, 
triglycerides (TG), total cholesterol levels (TC), low density lipoproteins 
(LDL), and very low density lipoproteins (VLDL). Thus the above results 
indicate that Anisomeles malabarica Linn has preventive effect on 
dexamethasone induced insulin resistance. 
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VIII. SUMMARY & CONCLUSION 
In the current research, we have investigated the effect of Anisomeles malabarica 
Linn on dexamethasone induced insulin resistance models. Various biochemical 
estimations like glucose, cholesterol. Triglycerides, LDL and HDL levels and anti-
oxidant estimations like TBARS SOD, CAT, and GSH were estimated in two 
different doses of Anisomeles malabarica Linn (100 and 200mg/kg p.o.) and then 
compared with the standard and induced compound. 
Anisomeles malabarica Linn at a dose of 100mg/kg and 200mg/kg prevented the 
development of hyperglycemia, hypercholesteremia and hypertriglyceridemia in 
dexamethasone induced insulin resistance models. Oral administration of 
Anisomeles malabarica Linn 100mg/kg and 200mg/kg reduces serum glucose, 
triglyceride, total cholesterols and LDL concentration and improve the 
concentration of HDL in dexamethasone administered rats. The lignin Anisomeles 
malabarica Linn showed significant anti-diabetic effect in rats after oral 
administration. 
The present study demonstrated that Anisomeles malabarica Linn could be useful 
in Management of diabetes associated with abnormalities in lipid profiles. Further 
study need to isolate, identify the active compounds and find out the possible 
mechanism of actions. 
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